Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

NMR vs TW: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

NMR Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 4–6 Matrix Metrics)

NMR Overall Winner 6-Pillar Tally: NMR 3 – 2 TW (1 Tie) Matrix Metrics: NMR 4 – 6 TW

As of Nov 17, 2026, Nomura Holdings, Inc (NMR) is the stronger overall head-to-head candidate over Tradeweb Markets Inc. (TW) in the Tradestie Institutional Equity Comparison Engine, winning 4–6 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, R&D & Supply-Chain Moat). NMR carries a Unified Composite Score of 44.5/100 (HOLD) at $9.34 (12.7x Forward P/E, 25.1% operating margin), whereas TW carries 44.3/100 (HOLD) at $129.76 (28.1x Forward P/E, 44.1% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About NMR vs TW
NMR NYSE Head-to-Head Winner
Nomura Holdings, Inc
Security Brokers, Dealers & Flotation Companies
$9.34
-1.74% 1D
Market Cap $28.3B
TTM Revenue $14.9B
Forward P/E 12.7x
Beta / 30D Vol 1.03β · 29% Vol
Unified Composite Score
44.5 / 100 HOLD
Tech 47.0 Fund 49.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 45
RSI-14: 45.5 · SMA20: $9.40 · SMA50: $9.68
TW NASDAQ
Tradeweb Markets Inc. Class A Common Stock
Security & Commodity Brokers, Dealers, Exchanges & Services
$129.76
-2.2% 1D
Market Cap $28.4B
TTM Revenue $2.28B
Forward P/E 28.1x
Beta / 30D Vol -0.33β · 22% Vol
Unified Composite Score
44.3 / 100 HOLD
Tech 17.0 Fund 29.0 Flow 50.0 Mom 21.1
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (7.5% over 20 days), RSI 73
RSI-14: 72.6 · SMA20: $125.85 · SMA50: $113.72

6-Pillar Scorecard Institutional Category Breakdown (NMR 3 – 2 TW)

Columns: Metric · NMR · TW
1. Valuation Multiples NMR
Forward P/E 12.7x 28.1x
Trailing P/E 11.2x 31.2x
PEG Ratio 0.81x 2.01x
EV / Revenue 1.9x 12.5x
2. Growth & Scale NMR
Revenue Growth (YoY) +17.9% +14.9%
Earnings Growth (YoY) +13.6% +9.1%
TTM Revenue (USD) $14.9B $2.28B
Market Cap $28.3B $28.4B
3. Profitability & Quality TW
Gross Margin 77.4% 92.9%
Operating Margin 25.1% 44.1%
Net Profit Margin 17.1% 39.9%
Return on Equity (ROE) 11.5% 14.5%
4. Balance Sheet & Cash Flow TW
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage $8.17 Book/Sh · 11.5% ROE $31.67 Book/Sh · 14.5% ROE
Dividend Yield 3.34% 0.41%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 30.7% (<1st %ile) 25.5% (<1st %ile)
Put/Call OI Skew Thin ADR Chain N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markup
6. R&D & Supply-Chain Moat NMR
OpEx & R&D Intensity 52.3% of Rev ($7.77B) 48.8% of Rev ($1.11B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat High-Margin Pricing Power Moat
Supply-Chain Role Capital Markets Operator Capital Markets Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: NMR (4) vs TW (6)
Institutional Metric NMR TW Criterion Row Edge
Market Capitalization
Scale
$28.3B $28.4B Larger Scale TW
Trailing P/E Ratio
Valuation
11.2x 31.2x Lower Multiple NMR
Forward P/E Ratio
Valuation
12.7x 28.1x Lower Multiple NMR
Revenue Growth (YoY)
Growth
+17.9% +14.9% Higher Growth NMR
Operating Margin (TTM)
Profitability
25.1% 44.1% Higher Margin TW
Net Profit Margin
Profitability
17.1% 39.9% Higher Margin TW
Return on Equity (ROE)
Capital Efficiency
11.5% 14.5% Higher ROE TW
52-Week Range Position
Momentum
60% ($7–$11) 89% ($91–$135) Stronger Trend TW
Beta / 30D Volatility
Risk Regime
1.03β · 29% Vol -0.33β · 22% Vol Lower Realized Risk TW
Unified Institutional Score
Composite Signal
44.5 / 100 (HOLD) 44.3 / 100 (HOLD) Higher Composite NMR
Trailing 12M Revenue (USD)
Operating Scale
$14.9B $2.28B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
77.4% 92.9% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.81x PEG · 1.9x EV/Rev 2.01x PEG · 12.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($8.17 Book/Sh · 11.5% ROE) N/A ($31.67 Book/Sh · 14.5% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon TW +10.77 pp
NMR: +2.36% · TW: +13.13%
3M Horizon TW +27.45 pp
NMR: -1.84% · TW: +25.61%
6M Horizon TW +0.38 pp
NMR: +16.69% · TW: +17.07%
1Y Horizon NMR +7.84 pp
NMR: +26.32% · TW: +18.48%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NMR vs TW. Trailing 12-month operating profitability (NMR 25.1% vs TW 44.1%) and valuation multiples (NMR 12.7x vs TW 28.1x Forward P/E) are benchmarked directly in Pillar 4 below.

NMR ADR TTM Benchmark FX-Normalized USD
TTM Revenue$14.9B
Gross Margin77.4%
Op. Margin25.1%
ROE / Fwd P/E11.5% · 12.7x
TW ADR TTM Benchmark FX-Normalized USD
TTM Revenue$2.28B
Gross Margin92.9%
Op. Margin44.1%
ROE / Fwd P/E14.5% · 28.1x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
NMR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 30.7%
IV Percentile <1st %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NMR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
TW UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 25.5%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact TW Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
NMR Moat Profile Scale & Operating Efficiency Moat
Capital Markets Operator
Competes within the Capital Markets value chain with $28.3B market capitalization and 25.1% operating margin.
OpEx & R&D Reinvestment 52.3% of Rev ($7.77B)
90D Engineering Disclosures 0 Published
TW Moat Profile High-Margin Pricing Power Moat
Capital Markets Operator
Competes within the Capital Markets value chain with $28.4B market capitalization and 44.1% operating margin.
OpEx & R&D Reinvestment 48.8% of Rev ($1.11B)
90D Engineering Disclosures 0 Published

Investor FAQ NMR vs TW Key Questions & Quantitative Answers

As of Nov 17, 2026, Nomura Holdings, Inc (NMR) is the stronger overall head-to-head candidate over Tradeweb Markets Inc. (TW) in the Tradestie Institutional Equity Comparison Engine, winning 4–6 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, R&D & Supply-Chain Moat). NMR carries a Unified Composite Score of 44.5/100 (HOLD) at $9.34 (12.7x Forward P/E, 25.1% operating margin), whereas TW carries 44.3/100 (HOLD) at $129.76 (28.1x Forward P/E, 44.1% operating margin). Technically, NMR sits in a Neutral phase (RSI 45.5, UNCLASSIFIED options structure) and TW sits in a Markup phase (RSI 72.6, UNCLASSIFIED options structure).

NMR leads the Growth & Scale pillar: NMR posts +17.9% YoY revenue growth and +13.6% YoY earnings growth on $14.9B TTM revenue (77.4% gross margin, 25.1% operating margin), compared with TW at +14.9% YoY revenue growth and +9.1% YoY earnings growth on $2.28B TTM revenue (92.9% gross margin, 44.1% operating margin). On trailing 12-month operating scale, NMR generates $14.9B in USD-normalized revenue versus $2.28B for TW. In operating R&D and SG&A reinvestment, NMR deploys 52.3% of Rev ($7.77B) (0 90-day corporate R&D disclosures) versus 48.8% of Rev ($1.11B) (0 disclosures) for TW.

NMR screens cheaper on headline valuation multiples. NMR trades at 12.7x Forward P/E, 11.2x Trailing P/E, 0.81x PEG, and 1.9x EV/Revenue (unreported cash flow margin), whereas TW trades at 28.1x Forward P/E, 31.2x Trailing P/E, 2.01x PEG, and 12.5x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NMR (11.5% ROE) versus TW (14.5% ROE) capital efficiency.

In options market volatility and institutional positioning, NMR carries 30.7% implied volatility (<1st %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.03β · 29% Vol realized risk). By comparison, TW carries 25.5% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.33β · 22% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.